Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 25, 2012
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus
Brian T Tsuji, Tanya Brown, Ridhi Parasrampuria, et al.
Nature Medicine
|
November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Marjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Nature Medicine
|
November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Marjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2015
Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform
Angela M Starks, Enrique Avilés, Daniela M Cirillo, et al.
The Journal of Infectious Diseases
|
March 14, 2015
Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis
Hugh Salamon, Ken D Yamaguchi, Daniela M Cirillo, et al.
Expert Review of Neurotherapeutics
|
December 27, 2014
Charting a path toward combination therapy for Alzheimer's disease
Diane Stephenson, Dan Perry, Cynthia Bens, et al.
BMC Infectious Diseases
|
April 3, 2022
Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts
Aksana Jones, Jay Saini, Belinda Kriel, et al.
Clinical Pharmacology and Therapeutics
|
February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future
Craig R Rayner, Patrick F Smith, David Andes, et al.
Expert Review of Neurotherapeutics
|
February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's disease
Daniel Perry, Reisa Sperling, Russell Katz, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 8, 2014
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop
Klaus Romero, Vikram Sinha, Sandra Allerheiligen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Antimicrobial Agents and Chemotherapy
|
April 25, 2012
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus
Brian T Tsuji, Tanya Brown, Ridhi Parasrampuria, et al.
Nature Medicine
|
November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Marjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Nature Medicine
|
November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Marjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2015
Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform
Angela M Starks, Enrique Avilés, Daniela M Cirillo, et al.
The Journal of Infectious Diseases
|
March 14, 2015
Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis
Hugh Salamon, Ken D Yamaguchi, Daniela M Cirillo, et al.
Expert Review of Neurotherapeutics
|
December 27, 2014
Charting a path toward combination therapy for Alzheimer's disease
Diane Stephenson, Dan Perry, Cynthia Bens, et al.
BMC Infectious Diseases
|
April 3, 2022
Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts
Aksana Jones, Jay Saini, Belinda Kriel, et al.
Clinical Pharmacology and Therapeutics
|
February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future
Craig R Rayner, Patrick F Smith, David Andes, et al.
Expert Review of Neurotherapeutics
|
February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's disease
Daniel Perry, Reisa Sperling, Russell Katz, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 8, 2014
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop
Klaus Romero, Vikram Sinha, Sandra Allerheiligen, et al.
Page
of 4